Normal
20th-21st October 2022

5th Annual MarketsandMarkets Real-World Evidence and Life Sciences Analytics Conference

Hilton Boston Logan Airport

MarketsandMarkets is proud to announce the 5th Annual Real-World Evidence and Life Sciences Conference to be held on October 20-21, 2022 in Boston, USA.

Real-world data and real-world evidence are poised to keep making strides in 2022.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.

Shifts in healthcare coverage and provision during the pandemic have changed the discovery and reporting of certain outcomes in data and the treated population. This means that disease trends may lead to incorrect interpretations when RWD and RWE are not framed in the context of the pandemic and long-term COVID-19 disease, therapy, and lifestyle changes. Telemedicine and virtual care may also provoke a greater adoption of technologies such as wearables and digital therapeutics, thus accelerating digitalization in the healthcare space and boosting the importance of RWE and AI.

Additionally with the new guidance by the FDA around data quality and data standards, the stakeholders are seeking to learn its long term impact and safety surveillance. This conference will focus on above said significant points and hold discussions on the best practices adopted by various stakeholders with a key takeaway being better decision making.

WHAT TO EXPECT

Key Highlights

  • Regulatory view around data quality & data standards.
  • Leveraging RWE for improving market access.
  • The adoption & role of AI & ML in clinical trials.
  • Real-world evidence & Digital Health - The expanded role of RWE for digital health.
  • Panel Discussion on lessons learned from the recent results of the FDA’s
    pilot program RCT DUPLICATE.
  • Real-World Data & Advanced Analytics.
  • RWE to inform decision making process in rare diseases where there is lack of evidence.

Why Attend?

  • Learn about the recent trends and advancements in Real-World Evidence Generation
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers

Who Should Attend?

From pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-

Real-World Evidence, Real-World Data, Health Economics & Outcomes Research- HEOR, Market Access/Value Access, Clinical Outcomes, Clinical Development & research, Clinical trial and others

CONFERENCE AGENDA
Enquire Now

Sponsor/Exhibit Delegate
CONFERENCE SPEAKERS
Advisors
Charles Makin
Charles Makin
Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen
Nneka Onwudiwe
Nneka Onwudiwe
Former PRO/PE Regulatory Review Officer, FOOD AND DRUG ADMINISTRATION
Joel Iff
Joel Iff
Senior Director Global Market Access, Sarepta Therapeutics, USA
Melva Covington
Melva Covington
Principal, AGAPE Strategic Solutions LLC
Speakers
Charles Makin
Charles Makin
Global Head of HEOR and RWE, Global Head of Pipeline Value & Access, Biogen
Nneka Onwudiwe
Nneka Onwudiwe
Former PRO/PE Regulatory Review Officer, FOOD AND DRUG ADMINISTRATION
Joel Iff
Joel Iff
Senior Director Global Market Access, Sarepta Therapeutics, USA
Melva Covington
Melva Covington
Principal, AGAPE Strategic Solutions LLC
Huan Huang
Huan Huang
Senior Director, Healh Economics & Outcomes Research (HEOR), G1 Therapeutics, USA
Jennifer Webster
Jennifer Webster
Senior Director, RWE Scientist Oncology Team Lead, Pfizer
Sunil Dravida
Sunil Dravida
Global Head of RWD Center of Excellence,, Takeda
Nathan Hill
Nathan Hill
Director, Real World Evidence Strategy and Innovations, BMS
SPONSORS
Gold
example-image

OM1

Silver
example-image

Picnic Health

Sponsors & Exhibitors
example-image

HealthVerity

Visiting Partners
example-image

PINC AI™ Applied Sciences (PAS)

example-image

Curebase

example-image

Eversana

example-image

RTI Health Solutions

example-image

Syneos Health®

Exhibition Partner
example-image

Adelphi Real World

PARTNERS
Supporting Association
Digital Analytics Association

Digital Analytics Association

LOCATION
Hilton Boston Logan Airport
About the Hotel

One Hotel Drive, Boston, MA 02128 USA

PAST EVENT GALLERY